| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/06/2009 | CA2711995A1 Novel n-(2-amino-phenyl)-amide derivatives |
| 08/05/2009 | EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade |
| 08/05/2009 | EP2085386A2 Pyridinium and quinolinium derivatives as Choline kinase inhibitors |
| 08/05/2009 | EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/05/2009 | EP2085087A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 08/05/2009 | EP2084132A1 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
| 08/05/2009 | EP2084127A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 08/05/2009 | EP2083821A1 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |
| 08/05/2009 | EP2083816A2 Heterocyclic amide compounds useful as kinase inhibitors |
| 08/05/2009 | EP1963270B1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents |
| 08/05/2009 | EP1753721B1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 08/05/2009 | EP1742707A4 Treatment of cns disorders using cns target modulators |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1399116B1 Use of dicationic compounds for dyeing human keratinous fibres and compositions containing same |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | CN101500999A Hydroxyphenyl derivatives and biological applications thereof |
| 08/05/2009 | CN101500998A Mono-and divalent salts of N-(5-hydroxynicotinoil)-L-glutaminic acid exhibiting psychotropic (antidepressant and anxyolytic), neuroprotective, heroprotective and cerebroprotective action |
| 08/05/2009 | CN101500986A Di-aromatic substituted amides as inhibitors for GLYT1 |
| 08/05/2009 | CN101497610A Dithiazole ethylene compound containing 2,1,3-diazosulfide unit |
| 08/05/2009 | CN100522948C Isopentyl carboxanilides for combating undesired micro-organisms |
| 08/05/2009 | CN100522945C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522943C Vitamin d analogues |
| 08/05/2009 | CN100522937C Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/05/2009 | CN100522934C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/05/2009 | CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 08/05/2009 | CN100522151C Compounds for treatment of inflammation, diabetes and related disorders |
| 08/05/2009 | CN100522150C Angiogenesis inhibitor |
| 08/04/2009 | US7569852 Transition metal complex and light-emitting device |
| 08/04/2009 | US7569727 Pesticidally active ketone and oxime derivatives |
| 08/04/2009 | US7569725 2-[(3-chloro-4-hydroxybenzoyl)amino]-N-[2-(2-methoxyphenyl)ethyl]-5-phenoxybenzamide; therapeutic use as anti-cancer agents, as well as other therapeutic agents, for example, as anti-fertility agents |
| 08/04/2009 | US7569724 Antiproliferative agnets; anticancer agents; skin disorders |
| 08/04/2009 | US7569703 Fluorinating agent and method for producing fluorine-containing compound using the same |
| 08/04/2009 | US7569692 Platinum complex of 6,6'-bis(2-methoxyphenyl)-2,2'-bipyridyl; complexes having a tridentate- or higher polydentate-chain structure ligand; durability; red, green, blue color purity; short wavelength; excellent in both luminous characteristics; displays; brightness; light sources |
| 08/04/2009 | US7569609 Treating Alzheimer's disease with 2-propylpentanoic acid (valproic acid) or salts thereof; improving the GABAA receptor responses |
| 08/04/2009 | US7569608 Pentanoic acid derivatives |
| 08/04/2009 | US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis |
| 08/04/2009 | US7569536 Broad spectrum antiviral including against SARS (severe acute respiratory syndrome), DNA viruses and herpes viruses; Ser-Arg (SR), SR proteins are RNA-binding proteins; compounds are SRPK inhibitors such as 1-piperidino-2-(pyridin-4-ylcarbonylamino)-4-trifluoromethylbenzene |
| 08/04/2009 | CA2568104C Intermediates useful in production of antivirally active heterocyclic azahexane derivatives |
| 07/30/2009 | WO2009094427A1 4-pyridinone compounds and their use for cancer |
| 07/30/2009 | WO2009093704A1 Diamine compound, liquid crystal aligning agent, and liquid crystal display device using the same |
| 07/30/2009 | WO2009067600A3 Biaryl pde4 inhibitors for treating inflammation |
| 07/30/2009 | WO2009024980A3 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors |
| 07/30/2009 | US20090192202 4-(2-Cyano-cyclohexyloxy)-2-trifluoromethyl-benzonitrlle; selective androgen receptor modulators; decrease excess sebum secretions; stimulants of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer |
| 07/30/2009 | US20090192200 Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereof |
| 07/30/2009 | US20090192190 Benzoic Acid Derivatives that are Modulators or Agonists of GlyR |
| 07/30/2009 | US20090192172 2-Alkyl-Cycloalk(en)yl-Carboxamides |
| 07/30/2009 | US20090192150 protease-activated receptor 1 (PAR1) inhibitors such as 1-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-(3-iminoimidazo[1,5-a]pyridin-2-yl)ethanone, used as anticoagulants |
| 07/30/2009 | US20090192127 Combination therapy comprising a diaryl urea compound and a p13, akt kinase or mtor inhibitors (rapamycins) for cancer treatment |
| 07/30/2009 | US20090192125 Local anti-infective agent for treatment of nail fungal infections |
| 07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
| 07/30/2009 | US20090192096 2'-Substituted 1,1'-Biphenyl-2-Carboxamides, Processes For Their Preparation, Their Use As Medicaments, And Pharmaceutical Preparations Comprising Them |
| 07/30/2009 | US20090189119 Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202 |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/29/2009 | EP2081905A2 Sulfonyl compounds which modulate the cb2 receptor |
| 07/29/2009 | EP2081903A2 2-aminocarbonyl-pyridine derivatives |
| 07/29/2009 | EP2081902A1 Polymorph iii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide |
| 07/29/2009 | EP2081901A1 Novel 2-amino-pyridine derivatives and their use as potassium channel modulators |
| 07/29/2009 | EP2081900A2 New n-(3-pyridin-2-ylpropyl)benzamide derivatives |
| 07/29/2009 | EP2081888A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 07/29/2009 | EP2081886A1 Method for producing alkaline (meth)acrylamides |
| 07/29/2009 | EP1979321B1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 07/29/2009 | EP1686119B1 Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors |
| 07/29/2009 | EP1409468B9 Guanidinobenzamides as mc4-r agonists |
| 07/29/2009 | EP1268443B1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/29/2009 | CN101495456A Substituted pyridyl amide compounds as modulators of the histamine H3 receptor |
| 07/29/2009 | CN101495455A Novel heterocyclic compounds |
| 07/29/2009 | CN101495454A Novel PDE4 inhibitors |
| 07/29/2009 | CN101495453A Process for the manufacture of HI-6 dimethanesulfonate |
| 07/29/2009 | CN101495452A EP2 agonists |
| 07/29/2009 | CN101492418A Method for preparing full substituted pyridinone of suspension amido |
| 07/29/2009 | CN101492417A Metallic copper chelidonamic acid complex and method for preparing the same |
| 07/29/2009 | CN101492416A Compounds effecting glucokinase |
| 07/29/2009 | CN101492415A Pyridine-2-sulfuryl arginine derivative and method for preparing the same |
| 07/29/2009 | CN101492414A Synthesis of polysubstituted pyridine-2(1H)-ketone compounds |
| 07/29/2009 | CN101492383A Process for making chiral 1,4-disubstituted piperazines |
| 07/29/2009 | CN100519573C Novel chemical substance having morphogenetic and growth-accelerating activities |
| 07/29/2009 | CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3 |
| 07/29/2009 | CN100519532C 6-alkyl or alkenyl-4-aminopicolinates and their use as herbicides |
| 07/29/2009 | CN100519531C Polysubstituted 1,1-pyridyloxycyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/29/2009 | CN100519530C Optical recording materials having high storage density |
| 07/29/2009 | CN100519529C Vapor phase catalytic chlorination of beta-picoline |
| 07/29/2009 | CN100519528C Compounds with analgesic effect |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518926C Ti-pillared clay based vandia catalyst and process for preparation |
| 07/28/2009 | US7567371 Electrochromic compounds |
| 07/28/2009 | US7566783 Long wavelength long lifetime luminophores |
| 07/28/2009 | US7566730 Substituted aminoethers for the treatment of Alzheimer's disease |
| 07/23/2009 | WO2009092070A1 Polymorph form iii of sorafenib tosylate, sorafenib tosylate methanol solvate and sorafenib tosylate ethanol solvate, and processes for preparation thereof |
| 07/23/2009 | WO2009091014A1 Phenyl acetamide derivative |
| 07/23/2009 | WO2009089680A1 Method of modulating membrane potential of a cell |
| 07/23/2009 | WO2009047568A3 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells |
| 07/23/2009 | WO2009027803A3 Polymorphs of (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)- phenoxy)-acetic acid, free acid |
| 07/23/2009 | WO2008087421A3 Male contraceptive |
| 07/23/2009 | WO2008076427A3 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 07/23/2009 | US20090187031 compounds which mimic the chemical and biological activity of discodermolide; may have use as anticancer agent |
| 07/23/2009 | US20090187026 Diastereomeric purification of rosuvastatin |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |